# Evolving Strategies in Amblyopia Management: From Traditional Therapies to Cutting-Edge Innovations

## TL;DR

This paper reviews traditional and new treatments for amblyopia, highlighting innovations like dichoptic therapy and technology-based approaches.

## Contribution

The paper provides an updated overview of evolving amblyopia treatments, emphasizing novel methods like dichoptic therapy and technological integration.

## Key findings

- Dichoptic therapy improves stereopsis by addressing neural suppression.
- Technologies like VR and AI enhance treatment compliance and personalization.
- Neuroplasticity research offers new hope for treating adult amblyopia.

## Abstract

Amblyopia, commonly referred to as "lazy eye," is a prevalent visual disorder affecting children and, in some cases, adults. Traditional treatments, including occlusion therapy and pharmacological approaches, have demonstrated efficacy but also face limitations related to adherence, age dependency, and recurrence rates. This narrative review explores evolving strategies in amblyopia management, from conventional therapies to emerging innovations. Dichoptic therapy, which leverages binocular visual stimulation, represents a paradigm shift by directly addressing neural suppression and improving stereopsis. Technological advancements, such as virtual reality (VR), AI, and eye-tracking technologies, have further revolutionized treatment approaches, enhancing compliance and enabling personalized care. Additionally, recent research in neuroplasticity has opened new avenues for treating adult amblyopia, challenging previous assumptions about its irreversibility. Despite these advancements, challenges persist in treatment standardization, accessibility, and long-term efficacy.